We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Leonard Saltz

Leonard B. Saltz MD

Chief, Gastrointestinal Oncology Service, Memorial Sloan–Kettering Cancer Center; Professor of Medicine, Weill Cornell Medical College, New York

Dr. Leonard Saltz is Chief of the Gastrointestinal Oncology Service at Memorial Sloan–Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College, both in New York City. In addition to leading many investigational trials at Memorial Sloan–Kettering, he has served as principal investigator on several multicenter national and international clinical trials. He is investigating a number of new potential anti-cancer agents, including targeted therapies, anti-angiogenic agents, and immunotherapies. He also is investigating the use of mutational analyses of individual tumors and measurements of the expression of specific genes within these tumors to help predict sensitivity or resistance to different chemotherapies. Dr. Saltz is a member of the NCCN Colorectal Guidelines Panel, the NCI Rectal Cancer Task Force, and the GI Core Committee of the Alliance NCI Cooperative Group.

 

Dr. Saltz received his undergraduate degree from Stanford University and his medical degree from Yale University School of Medicine. He completed his medical residency and his hematology/oncology fellowship at New York Presbyterian Hospital/Weill Cornell Medical College in New York City.